Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles

HRSA Administrator Thomas J. Engels Issues Dear Colleague Letter to RWCs

HIV/AIDS, HRSA, NewsBy Amber TynanApril 23, 2025

HRSA Administrator Thomas J. Engels Issues Dear Colleague Letter to RWCs HRSA Administrator Thomas J. Engels issued a letter to Ryan White Clinic HIV/AIDS Program awardees and stakeholders on April 7, 2025. …

RWC-340B Applauds Newly Reformulated Senate 340B Bipartisan Working Group

Congress, News, RWC-340BBy Amber TynanMarch 31, 2025

RWC-340B Applauds Newly Reformulated Senate 340B Bipartisan Working Group Bipartisan Working Group includes U.S. Senators Tammy Baldwin (D-Wis.), John Hickenlooper (D-Colo.), Tim Kaine (D-Va.), Shelley Moore Capito (R-W.V.), Jerry Moran…

Trump Administration Pauses Grantee Payments; Focus On Services Provided to Undocumented Patients

News, RWC-340B, White HouseBy Amber TynanJanuary 28, 2025

On January 20, 2025, President Trump issued an Executive Order that, among other things, paused distribution of federal funds under contracts, grants and agreements providing funding to non-governmental organizations “supporting…

Drug Makers Sue HRSA over 340B Participation of Certain STD Clinics

Drug Pricing, HRSA, News, RWC-340BBy Amber TynanDecember 31, 2024

On December 20, 2024, drugmakers Amgen Inc. (Amgen), Eli Lilly and Company (Eli Lilly), and UCB, Inc. (UCB), sued HHS, alleging that HHS has not fulfilled its obligations to oversee…

West Virginia Sides with Drug Manufacturers and Mississippi Rules Against AstraZeneca in State Contract Pharmacy Litigation

HRSA, News, Rulings, RWC-340BBy Amber TynanDecember 31, 2024

To close out the year, two federal judges issued conflicting opinions regarding the likelihood of success in challenges to state 340B contract pharmacy laws.  In the first major siding with…

Gilead PAP Changes

Drug Pricing, News, RWC-340BBy Amber TynanDecember 19, 2024

What is Changing:  Implementation Extended to January 31, 2025: Effective January 31, 2025, Gilead’s Patient Assistance Programs (PAPs), including Advancing Access, will stop providing free medications for medicines where there…

Sanofi Pauses Rebate Model; Files Lawsuit Against HRSA

HRSA, News, RWC-340BBy Amber TynanDecember 18, 2024

On December 16, Sanofi informed HRSA that it will pause the implementation of its rebate model, termed a “340B credit model.”  The same day, Sanofi filed a lawsuit in the…

HRSA Warns Sanofi Over Proposed Rebate Model; Alludes to Possible Termination of Pharmaceutical Pricing Agreement (PPA)

HRSA, News, RWC-340BBy Amber TynanDecember 16, 2024

On December 13th, the Health Resources and Services Administration (HRSA) issued a letter to Sanofi calling for the manufacturer to cease implementation of its rebate model, which Sanofi terms a…

SCOTUS Declines to Review Important Appellate Decision Protecting 340B Contract Pharmacy Arrangements in Arkansas

News, RWC-340BBy Amber TynanDecember 10, 2024

Yesterday, the Supreme Court denied PhRMA’s request for review of the Eighth Circuit’s decision upholding Arkansas Act 1103, which requires delivery of 340B drugs to an unlimited number of contract…

Bristol-Myers Squibb Sues To Implement Rebate Model; AbbVie Adds Grantees To Its Contract Pharmacy Policy

Drug Pricing, HRSA, News, RWC-340BBy Amber TynanDecember 6, 2024

Bristol-Myers Squibb Sues HHS To Implement 340B Rebate Model On November 26, 2024, Bristol-Myers Squibb (BMS) filed a lawsuit against HRSA in the D.C. District Court to defend its proposed…

→12345…
678910111213141516
17→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset